Outset Medical shares took a hit after the at-home dialysis tech company announced a shipment hold within its second-quarter results. Shares of OM fell 12.7% at $16.91 apiece in after-hours trading after the release of the news yesterday evening. By midday today, OM shares had recovered slightly, down more than 10% to $17.27 apiece MassDevice‘s […]
Outset Medical
Outset Medical stock sinks after it receives FDA warning letter
Outset Medical announced that it received a warning letter from the FDA related to its Tablo system. San Jose, California-based Outset previously disclosed an FDA Form 483 in its annual report in February. That FDA form identified four inspectional observations resulting from an inspection concluded on Feb. 10, 2023. From there, Outset provided a response […]
Outset Medical upgrades full-year guidance after strong Q1 performance
Outset Medical this week posted first-quarter results that beat the overall consensus on Wall Street. The San Jose, California-based dialysis company reported profit losses of $43.97 million, or 90¢ per share, on sales of $33.5 million, for the three months ended March 31, for a sales gain of 9.55% compared to Q1 2022. It had […]
Outset Medical beats The Street in Q4, reaffirms guidance
At-home hemodialysis technology developer Outset Medical (Nasdaq:OM) reported fourth-quarter results that topped the consensus forecast. Shares of OM, however, took a hit the morning following the company’s earnings call after the market closed yesterday. They dropped more than 12% to $25.02 apiece by midday. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest […]
The biggest medtech stock gainers, losers in 2022
In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most drastically. The MassDevice MedTech 100 Index, which includes stocks of the world’s largest medical device companies, reflects the performance of many in the medtech space. In a tough year for a lot of businesses, the Index […]
Axonics, Outset lead medtech space on Deloitte’s list of fastest growing companies
Deloitte today released its “North America Technology Fast 500” list of growing companies, including a handful of medtech firms. The list, which ranking of the fastest-growing North American companies across a range of sectors, included several “Life Sciences” outfits. Immunology company Vir Biotechnology led the way in first place on the list. Axonics (Nasdaq:AXNX) represented […]
Outset Medical skyrockets on Q3 revenue beat, raises full-year guidance
Outset Medical (Nasdaq:OM) this week posted third-quarter results that were in line with earnings estimates and beat the revenue consensus on Wall Street. The San Jose, California-based home hemodialysis device maker reported net losses of $40.8 million, or –85¢ per share, on sales of $27.8 million for the three months ended Sept. 30, for a […]
Outset Medical secures debt financing of up to $300M
Outset Medical (Nasdaq: OM) today announced two senior secured credit facilities with investment affiliates managed by SLR Capital Partners. Collectively, the facilities provide for up to $300 million in borrowing for the maker of the Tablo Hemodialysis System. The facilities include an up-to-$250-million term loan facility and an up-to-$50-million asset-based revolving credit facility. Outset drew $100 […]
Outset Medical unveils TabloCart for Tablo hemodialysis system
Outset Medical (Nasdaq:OM) this week launched the newest accessory for its Tablo Hemodialysis System, the TabloCart. The San Jose, California-based company designed TabloCart to help medical professionals easily move anywhere around the hospital. It provides added maneuverability and optional prefiltration or storage. [Hear more from Outset Medical CEO Leslie Trigg at DeviceTalks West on October 20] […]
10 big earnings stories from the last quarter: How are medtech stocks doing now?
Economic uncertainty appears to have produced a wide variety of medtech earnings stories during the most recent round of quarterly results. Some medical device companies received massive boosts from their quarterly performance, while others saw their stocks sink amid missed projections and other various issues. The phrase “macroeconomic headwinds” was a common phrase. Medtech faces […]
Outset Medical wins national VA contract
Outset Medical (Nasdaq:OM) announced today that it has won a national contract with the U.S. Department of Veterans Affairs to sell its Tablo hemodialysis system into the department’s 106 VA hospitals. San Jose, California–based Outset already has Tablo deployed at some VA hospitals, which overall provide dialysis for 35,000 U.S. veterans. But the new five-year […]
